Electrophysiology – News and Features

Cellumen announce a new Cellular Systems Biology panel to predict cardiac hypertrophy earlier in the drug discovery and development process.

Tufts study shows that changes in membrane voltage control timing of differentiation in adult stem cells.

Under the agreement TAP will co-develop and manufacture the Cellectricon’s high throughput ion channel screening platform.

The agreement is aimed at the development of electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.

The trial demonstrated a favorable safety profile with Vivecon in 55 subjects enrolled across 9 cohorts.

A new method for diagnosing heart attacks very early on could improve a patient's chances of survival and reduce the amount of permanent damage.

Sophion gains the right to provide ion channel cell lines from ChanTest that are optimized for Sophion’s QPatch automated patch clamp systems.

Sophion Bioscience A/S has announced an agreement with bSys that allows Sophion to sell a CHO-hERG cell line fully optimized for and validated on the QPatch automated patch clamp system.

ReachBio gains distribution rights to pure cardiomyocytes and other ES cell-derived products for drug discovery, toxicity testing, and R&D applications.

New ways to grow brain cells in the laboratory could eventually provide a way to treat Parkinson's disease, scientists say.